May 18, 2022 View Now: Generating Synthetic Longitudinal Data presented by Replica Analytics In this webinar, Replica Analytics’ Dr. Khaled El Emam is joined by Director of Data Science Lucy Mosquera to provide a gene
April 22, 2022 Perceptions of Parents, Nurses and Physicians Regarding Research Communication in the NICU: Results of an International Survey
May 23, 2022-February 8, 2024 View Now | International 2022 Drug-induced Kidney Injury Biomarker Workshop On May 23-24, 2022, the Critical Path Institute hosted the International Drug-induced Kidney Injury Biomarker Workshop. In collabo
Longtime Pharmaceutical Executive to Lead C-Path’s Sickle Cell Disease Consortium TUCSON, Ariz., April 14, 2022 – Critical Path Institute (C-Path) has named Sergey Rakhilin, Ph.D., as Executive Director of its
April 11, 2022 Quantitative System Pharmacology as a Legitimate Approach to Examine Extrapolation Strategies used to Support Pediatric Drug Development; Azer K, Barrett JS
April 11, 2022 Role of Disease Progression Models in Drug Development. Pharmaceutical Research; Jeffrey S Barrett, Tim Nicholas, Karim Azer, Brian W Corrigan
New logo! Rare Disease Cures Accelerator-Data and Analytics Platform has a new look! C-Path’s RDCA-DAP team is excited to unveil its new logo for the Rare Disease Cures Accelerator-Data and Analytics Platform
C-Path Receives Qualification Opinion from EMA on Type 1 Diabetes Biomarker Initiative TUCSON, Ariz., April 5, 2022 — Critical Path Institute’s (C-Path) Type 1 Diabetes Consortium (T1DC) today announced that the E